title: Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation.
authors.affiliation: Department of Surgery, Virchow-Klinikum, Humboldt University Berlin, Germany.
authors.forename: J M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: A
authors.initials: A
authors.lastname: Schneller
authors.forename: O
authors.initials: O
authors.lastname: Guckelberger
authors.forename: R
authors.initials: R
authors.lastname: Lohmann
authors.forename: U
authors.initials: U
authors.lastname: Neumann
authors.forename: S
authors.initials: S
authors.lastname: Jonas
authors.forename: J
authors.initials: J
authors.lastname: Klupp
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: M
authors.initials: M
authors.lastname: Knoop
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: P J
authors.initials: PJ
authors.lastname: Neuhaus
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; C079843:inolimomab; D016559:Tacrolimus